Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
2010 Standout
Hypertension, serum insulin, obesity and the metabolic syndrome
1998
Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome
1992
Thiazolidinediones
2004 Standout
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Triglycerides and Cardiovascular Disease
2011
Identification and Importance of Brown Adipose Tissue in Adult Humans
2009 Standout
Development of the Multiple Metabolic Syndrome: An Epidemiologic Perspective
1998
Adipokines, inflammation, and the endothelium in diabetes
2003
Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial
1993 Standout
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men
2002 Standout
Mortality during 25 Years of Follow-Up of a Cohort with Diabetes
1996
The metabolic syndrome
2010 Standout
Diet, Lifestyle, and the Risk of Type 2 Diabetes Mellitus in Women
2001 Standout
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
2009 Standout
Genetic and environmental determinants of non‐insulin‐dependent diabetes mellitus (NIDDM)
1992
Influence of hydrogenated fat and butter on CVD risk factors: remnant-like particles, glucose and insulin, blood pressure and C-reactive protein
2003
Uric Acid and Cardiovascular Risk
2008 Standout
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
2004 Standout
Maternal and child undernutrition: consequences for adult health and human capital
2008 Standout
Trans Fatty Acids and Cardiovascular Disease
2006 Standout
Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
1998 Standout
Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
1992 StandoutNature
Prevalence of NIDDM and impaired glucose tolerance in a rural and an urban population in Cameroon
1997
Insulin as a predictor of coronary heart disease: Interaction with apolipoprotein E phenotype A report from the multiple risk factor intervention trial
1994
The Cardiovascular Risk of Young Women with Polycystic Ovary Syndrome: An Observational, Analytical, Prospective Case-Control Study
2004
Prevalence of the metabolic syndrome in drug‐treated hypertensive patients and control subjects
1999
Obesity
2005 Standout
Serum Insulin and Incident Coronary Heart Disease in Middle-aged British Men
1996
Hyperinsulinemia and the Risk of Cardiovascular Death and Acute Coronary and Cerebrovascular Events in Men
2000
Growth hormone and metabolism
1988
Diabetes epidemiology as a tool to trigger diabetes research and care
1999
Hyperinsulinemia for the Development of Hypertension: Data from the Hawaii-Los Angeles-Hiroshima Study.
2001
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease
1994 Standout
Polycystic Ovary Syndrome
1995 Standout
Alcohol Consumption and Risk of Type 2 Diabetes Mellitus Among US Male Physicians
2000
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
2005 StandoutNature
Effects of Varying Carbohydrate Content of Diet in Patients With Non—Insulin-Dependent Diabetes Mellitus
1994
The relation of fetal growth to plasma glucose in young men
1992
Global and societal implications of the diabetes epidemic
2001 StandoutNature
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
The Effects of Treatment with Recombinant Human Growth Hormone on Body Composition and Metabolism in Adults with Growth Hormone Deficiency
1989 Standout
Prevalence of the Metabolic Syndrome Among US Adults
2002 Standout
Circulating concentrations of insulin markers and coronary heart disease: a quantitative review of 19 Western prospective studies
2007
Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data
1998
The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus
2001
Polycystic Ovary Syndrome
2005 Standout
Angiotensin Converting Enzyme Inhibitors and Progressive Renal Insufficiency
1989
Blood Pressure and End-Stage Renal Disease in Men
1996 Standout
Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose Tolerance
2003
Growth Allometry of the Organs in Giant Transgenic Mice*
1987
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
The metabolic syndrome—a new worldwide definition
2005 Standout
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)
1998
Relationship between birthweight and blood lipid concentrations in later life: evidence from the existing literature
2003
Diabetes, Plasma Insulin, and Cardiovascular Disease
2002
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Are Conventional Risk Factors for Mortality Relevant in Type 2 Diabetes?
1991
Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance
2001 Standout
Hyperinsulinemia as an Independent Risk Factor for Ischemic Heart Disease
1996
The changing face of macrovascular disease in non-insulin-dependent diabetes mellitus: an epidemic in progress
1997
Troglitazone Therapy Improves Endothelial Function to Near Normal Levels in Women with Polycystic Ovary Syndrome
2003
Association between Multiple Cardiovascular Risk Factors and Atherosclerosis in Children and Young Adults
1998 Standout
Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth
1993 Standout
Evidence for an independent relationship between insulin resistance and fasting plasma HDL‐cholesterol, triglyceride and insulin concentrations
1992
Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men
1995
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
2005 Standout
5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects.
1990
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Prediction of Coronary Heart Disease Using Risk Factor Categories
1998 Standout
Triglycerides and the Risk of Coronary Heart Disease
2006
Multivariate analysis of the insulin resistance syndrome in women.
1994
Role of insulin-like growth factors in embryonic and postnatal growth
1993 Standout
Free Fatty Acids Are Independently Associated with All-Cause and Cardiovascular Mortality in Subjects with Coronary Artery Disease
2006
Isolated Low HDL Cholesterol As a Risk Factor for Coronary Heart Disease Mortality
1997
Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.
1992
Fasting Serum Insulin Levels and Coronary Heart Disease in a Danish Cohort: 17-year Follow-up
1995
Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population
1980
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 Standout
Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
2008 Standout
Is metabolic syndrome a discrete entity in the general population? Evidence from the Caerphilly and Speedwell population studies
1998
Global Prevalence of Diabetes
2004 Standout
Insulin and Cardiovascular Disease: Paris Prospective Study
1991
The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]
2004
Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease
2016
Distribution and Correlates of Insulin in Elderly Men
1995
A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study.
1992
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
2003 Standout
Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
2010 Standout
Hyperinsulinemia Predicts Coronary Heart Disease Risk in Healthy Middle-aged Men
1998
The Metabolic Syndrome: Time for a Critical Appraisal
2005 Standout
Persistent Elevation of Plasma Insulin Levels Is Associated With Increased Cardiovascular Risk in Children and Young Adults
1996
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis.
2002
Human Aging: Usual and Successful
1987 StandoutScience
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia.
1993
Works of J M Warnet being referenced
Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up
1991
Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes
1989
High Plasma Nonesterified Fatty Acids Are Predictive of Cancer Mortality but Not of Coronary Heart Disease Mortality: Results from the Paris Prospective Study
2001
Cardiovascular and alcohol-related deaths in abnormal glucose tolerant and diabetic subjects
1992
The high risk of death by alcohol related diseases in subjects diagnosed as diabetic and impaired glucose tolerant: The paris prospective study after 15 years of follow-up
1991
Risk factors for early death in non-insulin dependent diabetes and men with known glucose tolerance status.
1993
Body mass, blood pressure, glucose, and lipids. Does plasma insulin explain their relationships?
1987
IS THE LEVEL OF SERUM TRIGLYCERIDE A SIGNIFICANT PREDICTOR OF CORONARY DEATH IN “NORMOCHOLESTEROLEMIC” SUBJECTS?
1986
Diabetes survey plasma insulin during 0-2h oral glucose tolerance test systematically carried out in a professional group
1971
THE LIVER AS A SOURCE OF SOMATOMEDIN
1976